The point of the article was that the FDA used to approve other manufacturers, but then required higher standards which only one manufacturer can meet. So now there's a de facto monopoly - not because of a patent, but because of the requirements the FDA set (retro-actively). The FDA needs to restrict itself to more basic testing (rather, testing requirements) so that the market can take over in the price setting of the drug through competition.
(I'm not an expert on the chemistry and medical aspects of pharma; actually I don't know anything about it. I don't know if, in the specific case of the article, the additional requirements set by the FDA are really required, or just paranoia. I think the FDA, and similar bodies in general, need to relax on their 'err on the side of caution' principle. To put it extremely - yes it sucks to be harmed by a thus far unknown side effect of a drug or food, but requiring near-100% safety on everything on the market hampers progress, and we can't know if the positive effect outweigh the negative ones. I hypothesize they don't, but until we know, let's lay off the state nannying, and replace it with a clearer mechanism to let consumers know how far something has been tested, so that they can make their own choices on whether or not they want to take/eat the drug/food).